Tumor risks of finerenone in patients with type 2 diabetes mellitus complicated with chronic kidney disease: a meta-analysis and systematic review of randomized …
Y Du, G Cao, L Gu, Y Chen, J Liu - Frontiers in Pharmacology, 2024 - frontiersin.org
Introduction: This study aimed to assess the tumor risk of finerenone in individuals with type
2 diabetes mellitus (T2DM) aggravated by chronic kidney disease (CKD). Methods: A …
2 diabetes mellitus (T2DM) aggravated by chronic kidney disease (CKD). Methods: A …